Gerd R Burmester Selected Research

sarilumab

1/2022	Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis.
11/2021	Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors.
10/2020	Efficacy and safety of sarilumab in combination with csDMARDs or as monotherapy in subpopulations of patients with moderately to severely active rheumatoid arthritis in three phase III randomized, controlled studies.
1/2020	Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.
1/2020	Association of High Serum Interleukin-6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis.
1/2020	EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
1/2020	Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes.
1/2019	Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension.
1/2019	Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment.
1/2018	Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerd R Burmester Research Topics

Disease

110	Rheumatoid Arthritis 04/2022 - 05/2003
20	Infections 04/2022 - 05/2008
16	Necrosis 10/2020 - 06/2007
12	Arthritis (Polyarthritis) 01/2020 - 08/2004
11	Psoriatic Arthritis 04/2022 - 04/2005
11	Rheumatic Diseases (Rheumatism) 01/2022 - 05/2010
11	Inflammation (Inflammations) 01/2021 - 11/2004
11	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 05/2003
9	Pain (Aches) 01/2022 - 10/2012
9	Fatigue 01/2022 - 01/2006
8	Herpes Zoster 04/2022 - 01/2018
7	Ankylosing Spondylitis 01/2020 - 08/2009
7	Systemic Scleroderma (Systemic Sclerosis) 01/2018 - 09/2008
6	Neoplasms (Cancer) 04/2022 - 04/2013
6	Chronic Disease (Chronic Diseases) 01/2022 - 10/2012
5	Vasculitis (Vasculitides) 01/2022 - 05/2004
5	Osteoarthritis 01/2021 - 08/2004
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2015 - 01/2006
4	Connective Tissue Diseases (Connective Tissue Disease) 05/2022 - 01/2009
4	Nasopharyngitis 04/2022 - 02/2013
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 04/2005
4	Fibrosis (Cirrhosis) 01/2018 - 01/2009
3	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022 - 01/2018
3	COVID-19 01/2022 - 01/2020
3	Disease Progression 01/2020 - 03/2011
3	Headache (Headaches) 01/2018 - 02/2013
3	Injection Site Reaction 05/2017 - 11/2010
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 04/2013 - 04/2013
3	digital ulcers 01/2009 - 09/2008
2	Anemia 04/2022 - 08/2009
2	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 07/2017
2	Ulcerative Colitis 01/2021 - 01/2020
2	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 02/2013
2	Skin Neoplasms (Skin Cancer) 01/2020 - 04/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020 - 01/2009
2	Crohn Disease (Crohn's Disease) 01/2020 - 04/2013
2	Melanoma (Melanoma, Malignant) 01/2020 - 04/2013
2	Nausea 01/2018 - 02/2013
2	Pulmonary Arterial Hypertension 10/2014 - 01/2009
2	Contracture 01/2009 - 01/2009
2	Ulcer 09/2008 - 08/2004

Drug/Important Bio-Agent (IBA)

25	Antirheumatic Agents (DMARD)IBA 04/2022 - 04/2005
25	Methotrexate (Mexate)FDA LinkGeneric 02/2022 - 01/2009
18	Adalimumab (Humira)FDA Link 04/2022 - 06/2007
15	Biological ProductsIBA 04/2022 - 05/2009
15	tocilizumab (atlizumab)FDA Link 01/2020 - 05/2011
14	CytokinesIBA 05/2022 - 09/2003
12	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2007
12	sarilumabIBA 01/2022 - 01/2017
10	Abatacept (Orencia)FDA Link 01/2020 - 01/2014
9	Janus Kinase InhibitorsIBA 04/2022 - 02/2013
9	tofacitinibIBA 02/2022 - 02/2013
8	AutoantibodiesIBA 01/2021 - 05/2003
8	Monoclonal AntibodiesIBA 01/2018 - 09/2011
7	Rituximab (Mabthera)FDA Link 01/2022 - 08/2009
7	GlucocorticoidsIBA 01/2021 - 01/2016
7	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2009
7	Pharmaceutical PreparationsIBA 01/2020 - 07/2012
7	AntibodiesIBA 01/2018 - 05/2004
6	GLPG0634IBA 04/2022 - 01/2020
6	Tumor Necrosis Factor InhibitorsIBA 11/2021 - 05/2011
6	ametantrone (HAQ)IBA 01/2018 - 10/2012
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 09/2003
5	upadacitinibIBA 04/2022 - 12/2016
5	AntigensIBA 01/2022 - 11/2006
5	Etanercept (Enbrel)FDA Link 01/2021 - 05/2009
5	InterleukinsIBA 01/2020 - 04/2007
5	AutoantigensIBA 01/2020 - 05/2003
5	Infliximab (Remicade)FDA Link 01/2020 - 04/2005
5	mavrilimumabIBA 01/2018 - 09/2011
4	omega-Chloroacetophenone (Mace)IBA 04/2022 - 01/2019
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2020 - 04/2013
4	golimumab FDA Link 01/2020 - 01/2018
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018 - 09/2011
3	Immunoglobulins (Immunoglobulin)IBA 05/2022 - 05/2008
3	ChemokinesIBA 05/2022 - 05/2004
3	baricitinibIBA 01/2022 - 01/2019
3	Leflunomide (Arava)FDA LinkGeneric 11/2021 - 01/2018
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 04/2012
3	Certolizumab Pegol FDA Link 01/2020 - 01/2009
3	Biosimilar PharmaceuticalsIBA 01/2020 - 03/2013
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 07/2012
3	C-Reactive ProteinIBA 01/2017 - 08/2009
3	Rheumatoid FactorIBA 05/2016 - 05/2004
2	vinyltriethoxysilane (VTES)IBA 04/2022 - 01/2021
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2022 - 01/2021
2	Interferon Type IIBA 01/2022 - 08/2017
2	VaccinesIBA 01/2022 - 01/2022
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021 - 10/2014
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2006
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 02/2013
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2012
2	acetyl 4-aminosalicylic acidIBA 01/2020 - 07/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 05/2004
2	EpitopesIBA 01/2020 - 01/2018
2	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 06/2017 - 09/2011
2	AngiotensinsIBA 10/2014 - 03/2011
2	Endothelins (Endothelin)IBA 10/2014 - 03/2011

Therapy/Procedure

37	Therapeutics 01/2022 - 11/2004
2	Drug Tapering 01/2020 - 01/2018